Oral Direct Factor Xa Inhibitors Versus Low-Molecular-Weight Heparin to Prevent Venous Thromboembolism in Patients Undergoing Total Hip or Knee Replacement: A Systematic Review and Meta-Analysis

Study Questions:

What are the benefits and harms of oral direct factor Xa inhibitors versus low molecular weight heparin (LMWH) to prevent venous thromboembolism (VTE) in patients undergoing total hip or knee replacement surgery?